Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival

Published:2017-05-23 Issue:8 Volume:21 Page:1226-1236
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Donadon Matteo,Hudspeth Kelly,Cimino Matteo,Di Tommaso Luca,Preti Max,Tentorio Paolo,Roncalli Massimo,Mavilio Domenico,Torzilli Guido

Funder

Italian Association for Cancer Research

Intramural Research Program of Humanitas Clinical and Research Center

Fondazione Umberto Veronesi

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/article/10.1007/s11605-017-3446-6/fulltext.html

Reference38 articles.

1. Cucchetti A, Ferrero A, Cescon M, Donadon M, Russolillo N, Ercolani G et al. Cure model survival analysis after hepatic resection for colorectal liver metastases. Ann Surg Oncol 2015;22:1908–14.

2. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008;371(9617):1007–16.

3. Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 2012;17:1225–39.

4. Folprecht G, Gruenberger T, Bechstein W, Raab HR, Weitz J, Lordick F et al. Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study). Ann Oncol 2014;25:1018–25.

5. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009;27:3677–83.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of tumor microenvironment alterations in partially responsive rectal cancer patients treated with neoadjuvant chemoradiotherapy;International Journal of Colorectal Disease;2024-06-26

2. Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review;Medical Oncology;2024-03-27

3. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy;Cells;2024-03-05

4. DPP7 as a Prognostic Marker for Colorectal Cancer;2023-10-19

5. The role of perfluorooctane sulfonic acid (PFOS) exposure in inflammation of intestinal tissues and intestinal carcinogenesis;Frontiers in Toxicology;2023-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3